Brief: Scancell Gets FDA Clearance Of IND Application For Iscib1+

Scancell Holdings

26/01/2026 07:13

Jan 26 (Reuters) - Scancell Holdings PLC SCLP.L:

SCANCELL HOLDINGS  - FDA CLEARANCE OF IND APPLICATION FOR ISCIB1+

SCANCELL HOLDINGS PLC - PHASE 3 TRIAL PLANNED TO START IN 2026

Source text: ID:nRSZ2266Qa

Further company coverage: SCLP.L

 ((Reuters.Briefs@thomsonreuters.com))